Alicia Gil | CEO&Owner
OMAKASE CONSULTING

CEO & Partner at Omakase Consulting S.L., with particular interest and experience in evidence generation in rare diseases and achieving Regulatory and Pricing & Market Access for orphan drugs in Spain. Held a number of previous positions as Senior Executive Director and Global Leader in the pharmaceutical and biotechnology industries and in strategic consultancy with responsibility to lead strategy and approvals in the areas of R&D, Business Development, Regulatory Affairs, Pricing and Reimbursement, Market Access, Corporate and Government Affairs, HEOR, Communication and Patient Advocacy. Directly responsible for multiple regulatory approvals with Medicines Agencies around the world and P&R and MA negotiations in Spain. Very active researcher in rare diseases and co-author of several scientific articles in this field. She holds an honours degree in Microbiology, an MSc(by research) in Biotechnology from Warwick University and a PhD (by research) in Molecular Biology by King's College. PDD by IESE Business School.